# Renalytix AI, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/renalytix-ai-inc/01f12260-1201-4ce3-9c45-dd8ea2280b8a

> Inspection records and compliance data for Renalytix AI, Inc. in New York, New York. Access full analysis and detailed observations.

---

## Details

- Name: Renalytix AI, Inc.
- FEI Number: 3018739912
- City: New York
- State: New York
- Country Name: United States
- Address Line 1: 101 6th Ave Fl 3 Rm 324
- Zip Code: 10013

## Related Documents

- [483 - Renalytix AI, Inc. - 2025-04-11](https://www.keypedia.com/records/483/renalytix-ai-inc/7c14ccd0-caf4-4565-8f86-31ba360441cc) — source: FDA, date: April 11, 2025
- [FDA Inspection 1268237 - Renalytix AI, Inc. - 2025-04-11](https://www.keypedia.com/records/fda_inspections/renalytix-ai-inc/f397c6cb-068b-4e74-b57d-fe5d0c4b2376) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 11, 2025
- [FDA Inspection 1268237 - Renalytix AI, Inc. - 2025-04-11](https://www.keypedia.com/records/fda_inspections/renalytix-ai-inc/b9a16959-b1db-4672-b611-fe130458cc16) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 11, 2025
- [FDA Inspection 1268237 - Renalytix AI, Inc. - 2025-04-11](https://www.keypedia.com/records/fda_inspections/renalytix-ai-inc/7593b93a-54f3-471d-9064-3125d79ee7df) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 11, 2025
- [FDA Inspection 1268237 - Renalytix AI, Inc. - 2025-04-11](https://www.keypedia.com/records/fda_inspections/renalytix-ai-inc/7046d358-0e00-412e-a415-1741ccfba507) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 11, 2025
- [FDA Inspection 1165285 - Renalytix AI, Inc. - 2022-03-01](https://www.keypedia.com/records/fda_inspections/renalytix-ai-inc/89a183b0-35a9-44c2-ba93-e2ead1b14b16) — classification: No Action Indicated (NAI), source: FDA, date: March 1, 2022
- [FDA Inspection 1165285 - Renalytix AI, Inc. - 2022-03-01](https://www.keypedia.com/records/fda_inspections/renalytix-ai-inc/1a17638c-a3aa-40c3-bdb5-a7cb29e59272) — classification: No Action Indicated (NAI), source: FDA, date: March 1, 2022

## Related Companies

- [Philips Respironics, Inc.](https://www.keypedia.com/companies/philips-respironics-inc/03ceee46-7a72-4590-8bc4-8033e1503cf3)
- [Reading Hospital](https://www.keypedia.com/companies/reading-hospital/06325159-9820-479a-ba2e-0f47aaa24d60)
- [Prolacta Bioscience Inc](https://www.keypedia.com/companies/prolacta-bioscience-inc/fafc52a9-8c2a-4c2a-9889-e42779d7c654)
- [General Physiotherapy Inc](https://www.keypedia.com/companies/general-physiotherapy-inc/922d654a-5b61-4e01-947b-bb0bb7300049)
- [Montefiore's Institute for Reproductive Medicine and Health](https://www.keypedia.com/companies/montefiores-institute-for-reproductive-medicine-and-health/c2c381cf-43a5-4aab-8eff-97119d58d36b)
- [Everything Sprouts, LLC](https://www.keypedia.com/companies/everything-sprouts-llc/d8ac40b4-d290-4435-b87d-4f3439e94693)
- [Ortho-Clinical Diagnostics, Inc.](https://www.keypedia.com/companies/ortho-clinical-diagnostics-inc/87658237-768e-419e-95c9-498cdd89acf6)
- [Arifulla Khan MD](https://www.keypedia.com/companies/arifulla-khan-md/311edd91-40e3-4296-9283-8ea2b60de005)
- [Primus Corporation dba Trinity Biotech](https://www.keypedia.com/companies/primus-corporation-dba-trinity-biotech/df325fd3-9d48-441b-a9f5-54b8401243c5)
- [Shore Institute For Reproductive Medicine, P.C.](https://www.keypedia.com/companies/shore-institute-for-reproductive-medicine-pc/0da28d4f-797f-44de-91b9-1fefa34d687a)

## Related Officers

- [Preston M. Lee](https://www.keypedia.com/people/preston-m-lee/e44adac3-a915-4bfb-8b06-a41ea5803358)